Mitsubishi UFJ Trust & Banking’s Agios Pharmaceuticals AGIO Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-210,920	Closed	-$6.83M	–	1324
2019 Q3	$6.83M	Buy	210,920 +2,220	+1%	+$91.9K	0.02%	660
2019 Q2	$10.4M	Sell	208,700 -2,760	-1%	-$148K	0.04%	495
2019 Q1	$14.3M	Sell	211,460 -3,020	-1%	-$176K	0.05%	387
2018 Q4	$9.89M	Sell	214,480 -23,570	-10%	-$1.45M	0.04%	450
2018 Q3	$18.4M	Sell	238,050 -4,360	-2%	-$351K	0.07%	340
2018 Q2	$20.4M	Sell	242,410 -9,000	-4%	-$785K	0.03%	532
2018 Q1	$20.6M	Buy	+251,410	New	+$19.4M	0.04%	517

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's AGIO Position: Q4 2019 in Review

Mitsubishi UFJ Trust & Banking sold out of Agios Pharmaceuticals (AGIO) in Q4 2019, closing a stake of 210,920 shares — an estimated $6.83M sold.

Mitsubishi UFJ Trust & Banking first reported a position in AGIO in Q1 2018 and held it in 7 quarters. The position peaked at $20.6M in Q1 2018. 199 funds tracked by Wall St. Rank hold AGIO as of Q4 2019.

Mitsubishi UFJ Trust & Banking reported no remaining Agios Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Mitsubishi UFJ Trust & Banking sold 210,920 Agios Pharmaceuticals shares in Q4 2019, an estimated $6.83M.
Mitsubishi UFJ Trust & Banking first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 7 quarters.
Mitsubishi UFJ Trust & Banking's Agios Pharmaceuticals position peaked at $20.6M in Q1 2018.
199 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2019.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q4 2019, filed 14 Feb 2020.